US FDA’s Advertising Enforcement Crackdown Expands To Generic Drugs

 
• By Sue Sutter
  
TV set
The FDA sent untitled letters to AstraZeneca and SK Life Science for violative TV commercials. (Shutterstock)

More from Marketing & Advertising

More from Compliance